AMR Action Fund

Funding rounds backed by AMR Action Fund.

Export CSV
Funding disclosed in full
$77.1M
Median round
$9M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Vedanta Biosciences

Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection

$60MGrowthBiotechUnited States
3 participantsAMR Action FundBARDABNP Paribas Asset Management Alts
Trellis Bioscience

Developing native human monoclonal antibodies to treat intractable infectious diseases

$9MSeries CBiotechUnited States
4 participantsAMR Action FundEaston CapitalNew Science VenturesThe Doctor Group
Centauri Therapeutics

Develops immunotherapeutic treatments for antimicrobial infections

£6MSeries A+BiotechUnited Kingdom
1 participantAMR Action Fund